Status:

UNKNOWN

Biomarkers Related to Bone in Pediatric Gaucher Disease

Lead Sponsor:

Lysosomal and Rare Disorders Research and Treatment Center, Inc.

Conditions:

Gaucher Disease

Bone Diseases

Eligibility:

All Genders

5-21 years

Brief Summary

Aims of the observational study is to establish novel blood-based biomarkers for grading bone disease in pediatric patients with Gaucher disease (GD). Patients with clinically confirmed GD: deficient ...

Detailed Description

Gaucher disease (GD), the most common lysosomal storage disorder, is caused by a deficiency of the enzyme glucocerebrosidase. Clinically, there are three sub-types according to neurological involvemen...

Eligibility Criteria

Inclusion

  • The parent or legal guardian and the participant who is eligible to provide assent are able and willing to provide informed consent and assent when applicable.
  • The participant is 5-21 years of age at the initial visit.
  • The participant has a confirmed diagnosis of GD type 1 or type 3 (biochemically and/or genetically).
  • In the investigator's opinion, the subject is capable of understanding and complying with protocol requirements.
  • The subject or, when applicable, the subject's legally acceptable representative signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.

Exclusion

  • Any subject who does not meet any of the following criteria will not qualify for the study.
  • Any current active chronic infection such as HIV, Hepatitis B or C.
  • Pregnancy or breastfeeding for females.

Key Trial Info

Start Date :

November 25 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06116071

Start Date

November 25 2023

End Date

December 31 2025

Last Update

March 13 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lysosomal and Rare disorder research and treatment center

Fairfax, Virginia, United States, 22030